---
title: "Bethany Sensenig appointed to Alpha board as director"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283402400.md"
description: "Alpha has appointed Bethany Sensenig as a director, effective April 15, 2026. Sensenig has a strong background, having served as the former CFO & Head of Operations at Radius Health and held various finance roles at other companies, including Biogen. The reason for her appointment and any replacement information have not been disclosed. This change was filed with the SEC under Alpha Cognition Inc. [ACOG]."
datetime: "2026-04-20T21:03:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283402400.md)
  - [en](https://longbridge.com/en/news/283402400.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283402400.md)
---

# Bethany Sensenig appointed to Alpha board as director

**Alpha appointed Bethany Sensenig as a director, effective April 15, 2026.**

**Individual**

Bethany Sensenig

**Role**

Director

**Type of Change**

Appointed

**Effective Date**

April 15, 2026

**Reason**

Not disclosed

**Replacement Info**

Not disclosed

**Background Details**

Former CFO & Head of Operations at Radius Health (May 2024–Apr 2026); prior CFO/Interim CEO at 9 Meters Biopharma; CFO & Head of U.S. Ops at Minovia; 13 years at Biogen in finance/commercial roles; board member at Supernus and KalVista.

**Board/Committee Role Changes**

Not disclosed

Original SEC Filing: Alpha Cognition Inc. \[ ACOG \] - 8-K - Apr. 20, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [ACOG.US](https://longbridge.com/en/quote/ACOG.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [NMTRQ.US](https://longbridge.com/en/quote/NMTRQ.US.md)
- [BIIB.US](https://longbridge.com/en/quote/BIIB.US.md)
- [SUPN.US](https://longbridge.com/en/quote/SUPN.US.md)
- [KALV.US](https://longbridge.com/en/quote/KALV.US.md)

## Related News & Research

- [Eton Secures U.S. IMPAVIDO Rights; $4.25M Fees, Up To $4M Milestones And 50-55% Revenue Share](https://longbridge.com/en/news/286966420.md)
- [Bicara Therapeutics: 1500mg Ficerafusp Alfa + Pembrolizumab Shows Estimated 31% 3‑Year OS in 1L R/M HPV‑Negative HNSCC](https://longbridge.com/en/news/287274216.md)
- [Biogen Conference: Lupus, Kidney Programs Take Center Stage in Immunology Push](https://longbridge.com/en/news/286623100.md)
- [Zentalis to Present Phase 1b MUIR Data: 39% ORR, 7.3‑month PFS; 50% ORR at 250 mg Cohort](https://longbridge.com/en/news/287276070.md)
- [Shah Capital Management Will Vote ‘No' Across Five Proposals On Novavax's June 18 Ballot - SEC Filing](https://longbridge.com/en/news/286565204.md)